ホーム › 急性骨髄性白血病 › コロンビア特別区 › Washington
Washington、DCにおける急性骨髄性白血病の臨床試験
Washingtonとその周辺地域（約30マイル以内）の拠点で、急性骨髄性白血病に関する24件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
被験者募集中第2相
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
被験者募集中第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- Center for Cancer and Blood Disorders, Bethesda · 7マイル先
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
被験者募集中第3相
- MedStar Georgetown University Hospital, Washington D.C.
- Children's National Medical Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7マイル先
Longitudinal Studies of Patient With FPDMM
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
被験者募集中第1/2相健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
被験者募集中観察研究
- The Center for Cancer and Blood Disorders, Bethesda · 7マイル先
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
被験者募集中第1/2相
- Children's National Medical Center, Washington D.C.
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- Children's National - Main Hospital, Washington D.C.
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
被験者募集中第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
被験者募集中第1相
- Childrens National Medical Center, Washington D.C.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 7マイル先
- Nih/Nhlbi, Bethesda · 7マイル先
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
被験者募集中観察研究
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
被験者募集中第1/2相
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7マイル先
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
被験者募集中観察研究健康なボランティア歓迎
- Cancer Support Community Research & Training Institute, Washington D.C.
Massage Impact on Sleep in Pediatric Oncology
被験者募集中
- Children's National Hospital, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
被験者募集中第1/2相
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Phase IB/II of CPX-351 for Relapse Prevention in AML
被験者募集中第1/2相
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
他の都市における急性骨髄性白血病の試験
- Houston, TX85件の研究
- New York City, NY51件の研究
- Boston, MA44件の研究
- Seattle, WA41件の研究
- Baldwin Park, CA40件の研究
- Columbus, OH35件の研究
- Philadelphia, PA34件の研究
- Durham, NC33件の研究
- Atlanta, GA31件の研究
- Tampa, FL29件の研究
- Chicago, IL26件の研究
- Portland, OR25件の研究
Washingtonにおける他の研究
- がん（全種類）58件の研究
- 非小細胞肺癌55件の研究
- 乳がん46件の研究
- 転移性癌43件の研究
- 肺がん41件の研究
- 前立腺がん38件の研究
- 肥満症33件の研究
- 大腸癌29件の研究
- 心血管疾患28件の研究
- 膀胱癌26件の研究
- 卵巣がん23件の研究
- リンパ腫23件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。